Product NDC: | 51097-001 |
Proprietary Name: | Adasuve |
Non Proprietary Name: | loxapine |
Active Ingredient(s): | 10 mg/1 & nbsp; loxapine |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | AEROSOL, POWDER |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51097-001 |
Labeler Name: | Alexza Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022549 |
Marketing Category: | NDA |
Start Marketing Date: | 20121221 |
Package NDC: | 51097-001-02 |
Package Description: | 5 INHALER in 1 CARTON (51097-001-02) > 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) |
NDC Code | 51097-001-02 |
Proprietary Name | Adasuve |
Package Description | 5 INHALER in 1 CARTON (51097-001-02) > 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) |
Product NDC | 51097-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loxapine |
Dosage Form Name | AEROSOL, POWDER |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20121221 |
Marketing Category Name | NDA |
Labeler Name | Alexza Pharmaceuticals, Inc. |
Substance Name | LOXAPINE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes |